Nucleic Acid Amplification Testing Market Size, Share, & Industry Analysis Report: By Type (PCR Tests, INAAT Tests, and LCR Tests), By Application, By End Use, and By Region

Description

List of Tables

The global nucleic acid amplification testing market size is expected to reach USD 28.86 billion by 2034, according to a new study by Polaris Market Research. The report "Nucleic Acid Amplification Testing Market Size, Share, & Industry Analysis Report: By Type (PCR Tests, INAAT Tests, and LCR Tests), By Application, By End Use, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Nucleic acid amplification testing, or NAAT, constitutes a powerful suite of molecular techniques designed to pinpoint specific genetic material, encompassing both DNA and RNA, within a biological specimen. The fundamental principle of these tests lies in their capacity to amplify even trace amounts of target nucleic acids to detectable levels. This amplification is essential for achieving the high sensitivity required for early and accurate diagnosis, particularly when dealing with pathogens present in low concentrations or identifying subtle genetic variations that might otherwise go unnoticed. The precision and sensitivity offered by NAAT have established it as a cornerstone in modern diagnostics, playing a pivotal role in clinical decision-making across a spectrum of medical disciplines.

The persistent threat of infectious diseases, including the emergence of novel pathogens and the resurgence of existing ones, necessitates the widespread adoption of sensitive diagnostic tools such as NAAT for effective disease management and containment. Furthermore, the increasing prevalence of genetic disorders and the expanding application of molecular diagnostics in oncology are significant drivers for the market demand trends of NAAT. Ongoing advancements in molecular technologies, leading to the development of more rapid, user-friendly, and cost-effective NAAT platforms, are also broadening their applicability and accessibility, further contributing to the development of these crucial diagnostic assays.

Nucleic Acid Amplification Testing Market Report Highlights:

By type, the polymerase chain reaction (PCR) tests segment held the largest share globally in 2024 due to their high specificity, sensitivity, and broad applicability across various diagnostic areas. Isothermal nucleic acid amplification technology (INAAT) tests are anticipated to exhibit the highest growth rate during the forecast period, driven by the increasing demand for rapid and point-of-care testing solutions.

By application, the infectious disease testing segment constituted the largest application segment in 2024, fueled by the widespread use of NAAT for diagnosing and monitoring a wide array of infectious agents. Oncology testing is expected to be the fastest-growing application segment, driven by the increasing adoption of molecular diagnostics in cancer management and personalized medicine approaches.

By end use, the central and reference laboratories segment accounted for the largest share of the nucleic acid amplification testing market in 2023, attributed to the high volume of tests processed in these facilities and their role as key hubs for specialized testing. The hospitals segment is projected to demonstrate the highest growth rate, driven by the increasing integration of advanced molecular diagnostics within hospital settings for rapid and improved patient care.

By region, North America held the largest share of the market in 2024. The Asia Pacific nucleic acid amplification testing market is projected to record the highest growth rate during the forecast period.

A few of the major players actively operating in the market are F. Hoffmann-La Roche AG; Abbott Laboratories; Thermo Fisher Scientific Inc.; QIAGEN N.V.; bioMerieux S.A.; Becton, Dickinson and Company (BD); Siemens Healthineers AG; Danaher Corporation (Cepheid); Hologic, Inc.; Agilent Technologies, Inc.; and Illumina, Inc.

Polaris Market Research has segmented the nucleic acid amplification testing market report on the basis of type, application, end use, and region:

By Type Outlook (Revenue - USD Billion, 2020-2034)

PCR Tests

INAAT Tests

LCR Tests

By Application Outlook (Revenue - USD Billion, 2020-2034)

Infectious Disease Testing

Oncology Testing

Genetic & Mitochondrial Disease Testing

Others

By End Use Outlook (Revenue - USD Billion, 2020-2034)

Hospitals

Central

Reference Laboratories

Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

Canada

Mexico

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Rest of Latin America

Product Code: PM5711

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Nucleic Acid Amplification Testing Market Insights

4.1. Nucleic Acid Amplification Testing Market - Market Snapshot
4.2. Nucleic Acid Amplification Testing Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Global Prevalence of Infectious Diseases
  - 4.2.1.2. Increasing Incidence of Genetic Disorders
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High cost and need for specialized equipment
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Nucleic Acid Amplification Testing Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Nucleic Acid Amplification Testing Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
5.3. PCR Tests
- 5.3.1. Global Nucleic Acid Amplification Testing Market, by PCR Tests, by Region, 2020-2034 (USD Billion)
5.4. INAAT Tests
- 5.4.1. Global Nucleic Acid Amplification Testing Market, by INAAT Tests, by Region, 2020-2034 (USD Billion)
5.5. LCR Tests
- 5.5.1. Global Nucleic Acid Amplification Testing Market, by LCR Tests, by Region, 2020-2034 (USD Billion)

6. Global Nucleic Acid Amplification Testing Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
6.3. Infectious Disease Testing
- 6.3.1. Global Nucleic Acid Amplification Testing Market, by Infectious Disease Testing, by Region, 2020-2034 (USD Billion)
6.4. Deep Tensor
- 6.4.1. Global Nucleic Acid Amplification Testing Market, by Deep Tensor, by Region, 2020-2034 (USD Billion)
6.5. Oncology Testing
- 6.5.1. Global Nucleic Acid Amplification Testing Market, by Oncology Testing, by Region, 2020-2034 (USD Billion)
6.6. Genetic & Mitochondrial Disease Testing
- 6.6.1. Global Nucleic Acid Amplification Testing Market, by Genetic & Mitochondrial Disease Testing, by Region, 2020-2034 (USD Billion)
6.7. Others
- 6.7.1. Global Nucleic Acid Amplification Testing Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Nucleic Acid Amplification Testing Market, by End Use

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
7.3. Hospitals
- 7.3.1. Global Nucleic Acid Amplification Testing Market, by Hospitals, by Region, 2020-2034 (USD Billion)
7.4. Central
- 7.4.1. Global Nucleic Acid Amplification Testing Market, by Central, by Region, 2020-2034 (USD Billion)
7.5. Reference Laboratories
- 7.5.1. Global Nucleic Acid Amplification Testing Market, by Reference Laboratories, by Region, 2020-2034 (USD Billion)
7.6. Others
- 7.6.1. Global Nucleic Acid Amplification Testing Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Nucleic Acid Amplification Testing Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Nucleic Acid Amplification Testing Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. Nucleic Acid Amplification Testing Market - North America
- 8.3.1. North America: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
- 8.3.3. North America: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.3.4. Nucleic Acid Amplification Testing Market - U.S.
  - 8.3.4.1. U.S.: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.3.5. Nucleic Acid Amplification Testing Market - Canada
  - 8.3.5.1. Canada: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
8.4. Nucleic Acid Amplification Testing Market - Europe
- 8.4.1. Europe: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
- 8.4.3. Europe: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.4.4. Nucleic Acid Amplification Testing Market - UK
  - 8.4.4.1. UK: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.4.5. Nucleic Acid Amplification Testing Market - France
  - 8.4.5.1. France: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.4.6. Nucleic Acid Amplification Testing Market - Germany
  - 8.4.6.1. Germany: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.4.7. Nucleic Acid Amplification Testing Market - Italy
  - 8.4.7.1. Italy: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.4.8. Nucleic Acid Amplification Testing Market - Spain
  - 8.4.8.1. Spain: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.4.9. Nucleic Acid Amplification Testing Market - Netherlands
  - 8.4.9.1. Netherlands: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.4.10. Nucleic Acid Amplification Testing Market - Russia
  - 8.4.10.1. Russia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.4.11. Nucleic Acid Amplification Testing Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
8.5. Nucleic Acid Amplification Testing Market - Asia Pacific
- 8.5.1. Asia Pacific: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.5.4. Nucleic Acid Amplification Testing Market - China
  - 8.5.4.1. China: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.5.5. Nucleic Acid Amplification Testing Market - India
  - 8.5.5.1. India: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.5.6. Nucleic Acid Amplification Testing Market - Malaysia
  - 8.5.6.1. Malaysia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.5.7. Nucleic Acid Amplification Testing Market - Japan
  - 8.5.7.1. Japan: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.5.8. Nucleic Acid Amplification Testing Market - Indonesia
  - 8.5.8.1. Indonesia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.5.9. Nucleic Acid Amplification Testing Market - South Korea
  - 8.5.9.1. South Korea: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.5.10. Nucleic Acid Amplification Testing Market - Australia
  - 8.5.10.1. Australia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.5.11. Nucleic Acid Amplification Testing Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
8.6. Nucleic Acid Amplification Testing Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.6.4. Nucleic Acid Amplification Testing Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.6.5. Nucleic Acid Amplification Testing Market - UAE
  - 8.6.5.1. UAE: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.6.6. Nucleic Acid Amplification Testing Market - Israel
  - 8.6.6.1. Israel: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.6.7. Nucleic Acid Amplification Testing Market - South Africa
  - 8.6.7.1. South Africa: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.6.8. Nucleic Acid Amplification Testing Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
8.7. Nucleic Acid Amplification Testing Market - Latin America
- 8.7.1. Latin America: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.7.4. Nucleic Acid Amplification Testing Market - Mexico
  - 8.7.4.1. Mexico: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.7.5. Nucleic Acid Amplification Testing Market - Brazil
  - 8.7.5.1. Brazil: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.7.6. Nucleic Acid Amplification Testing Market - Argentina
  - 8.7.6.1. Argentina: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
- 8.7.7. Nucleic Acid Amplification Testing Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Abbott Laboratories
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Agilent Technologies, Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Becton, Dickinson and Company (BD)
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. bioMerieux S.A.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Danaher Corporation (Cepheid)
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. F. Hoffmann-La Roche AG
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Hologic, Inc.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Illumina, Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. QIAGEN N.V.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Siemens Healthineers AG
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Thermo Fisher Scientific Inc.
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development